With reference to the captioned subject, we would like to inform you that company has entered into a Share Purchase Agreement ( SPA ) with Bizotic Lifescience Private Limited.
AHCL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.3 pts less than Nifty Microcap 250 and 1.2 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Anlon Healthcare Limited has signed a Share Purchase Agreement (SPA) with Bizotic Lifescience Private Limited to acquire shares in the company. The announcement does not disclose the deal size, consideration amount, or the stake being acquired. Bizotic Lifescience is a private company, and the SPA marks the formal step towards this acquisition. Further details on valuation, regulatory approvals, and timeline are awaited in subsequent disclosures.
This acquisition could expand Anlon Healthcare's business portfolio if Bizotic Lifescience is in a related sector, but without deal details, investors should wait for further disclosures to assess financial impact and any potential open offer obligation under SEBI takeover norms.